Oriol Calvete

8PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersInfant and child healthMedical biotechnology diagnostics (incl. biosensors)Free radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2026
Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Feb 13, 2025
Prenatal and Perinatal Factors Associated with Infant Acute Lymphoblastic Leukaemia: A Scoping Review.

Arantza Sanvisens, Clara Bueno, Oriol Calvete

|Oct 17, 2024
Beyond myeloid neoplasms germline guidelines: Validation of the thresholds criteria in the search of germline predisposition variants.

Julia Mestre, Lorea Chaparro, Ana Manzanares

|Dec 23, 2023
Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.

Oriol Calvete, Julia Mestre, Ruth M Risueño

|Jun 23, 2022
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function.

Maurice Michel, Carlos Benítez-Buelga, Patricia A Calvo

Pageof 2

Frequent Collaborators

4 joint publications

Francesc Solé

3 joint publications

Julia Mestre

2 joint publications

Blanca Xicoy

2 joint publications

Lurdes Zamora